Organisation and quality of primary surgical intervention for ovarian cancer in Denmark
- PMID: 17851818
- DOI: 10.1080/00016340701622294
Organisation and quality of primary surgical intervention for ovarian cancer in Denmark
Abstract
Background: The positive effect on survival of maximal primary cytoreductive surgery for ovarian cancer is well established, and the highest rates of optimal cytoreduction are achieved by gynecological oncologists. Danish women have not only one of the highest incidences of ovarian cancer, but also the highest mortality rate. From 1981 to 1989, the overall Danish optimal debulking rate was 25% in patients with stage III and IV tumors. The primary aim of the present study was, therefore, to evaluate the organisation and quality of current primary surgical intervention for ovarian cancer in Denmark.
Methods: All women diagnosed with epithelial ovarian carcinoma (DC56) were identified through the Danish National Patient Registry during the study period from 1 July 2002 to 31 December 2003, and surgical notes and histopathology were evaluated by a board of 7 gynecological-oncologists, focusing on maximal cytoreduction.
Results: For stage III, the nationwide optimal debulking rate was 39%, significantly higher in the major hospitals (49%) versus other hospitals (29%) (p<0.005). In 19% of cases, there was insufficient information to evaluate debulking from the surgical notes, significantly less at the major hospitals versus other hospitals (12 versus 25%, p<0.001).
Conclusions: In Denmark, the quality of the primary surgical intervention for ovarian cancer is not optimal. In order to enhance survival, compliance with international guidelines and improved registration of the surgical procedures in clinical databases are mandatory.
Similar articles
-
[Ovarian cancer in Denmark. Status of the surgical intervention].Ugeskr Laeger. 2006 Apr 10;168(15):1537-40. Ugeskr Laeger. 2006. PMID: 16640975 Danish.
-
The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.Gynecol Oncol. 2006 Dec;103(3):977-84. doi: 10.1016/j.ygyno.2006.06.004. Epub 2006 Jul 11. Gynecol Oncol. 2006. PMID: 16837030
-
What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?Gynecol Oncol. 2001 Sep;82(3):489-97. doi: 10.1006/gyno.2001.6312. Gynecol Oncol. 2001. PMID: 11520145
-
Who should operate on patients with ovarian cancer? An evidence-based review.Gynecol Oncol. 2005 Nov;99(2):447-61. doi: 10.1016/j.ygyno.2005.07.008. Epub 2005 Aug 29. Gynecol Oncol. 2005. PMID: 16126262 Review.
-
[Current surgical management in ovarian cancer recurrences].Minerva Ginecol. 2004 Oct;56(5):457-67. Minerva Ginecol. 2004. PMID: 15531862 Review. Italian.
Cited by
-
Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly.Obstet Gynecol. 2011 Sep;118(3):537-547. doi: 10.1097/AOG.0b013e31822a6d56. Obstet Gynecol. 2011. PMID: 21860281 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical